ClearKone® prescribed to more than 16,000 patients in 32 countries
SynergEyes, Inc., the leader in hybrid contact lens technology, announced that ClearKone®, its second generation hybrid contact lens for irregular corneas, has been prescribed to more than 16,000 patients in 32 countries since the lens became available in late 2009.
German pharmaceutical company Boehringer Ingelheim said Wednesday its oral blood-thinning drug Pradaxa for the prevention of stroke and embolism in patients with irregular heart beat has been approved in Canada.